📅 2026 Update: Recent Advances in Mesothelioma Treatment and Legal Landscape

Since the original article on doxurbicin was published, there have been significant updates in the treatment options for mesothelioma. Two notable immunotherapy drugs received FDA approval, and new guidelines on surgical treatment have been established. The information below highlights the most relevant changes for patients and families dealing with mesothelioma.

🧪 FDA Approvals for New Treatments

In September 2024, the FDA approved Keytruda® (pembrolizumab) for use with pemetrexed and platinum chemotherapy. This combination is now a first-line treatment for unresectable advanced or metastatic pleural mesothelioma. A clinical trial showed a median overall survival of 17.3 months with this combination, compared to 16.1 months for chemotherapy alone.

In 2024, the FDA also approved the combination of Opdivo® (nivolumab) and Yervoy® (ipilimumab) for treating inoperable malignant pleural mesothelioma. The CheckMate 743 trial found that this combination resulted in a median overall survival of 18.1 months, better than the 14.1 months seen with traditional chemotherapy.

🏥 Updated Surgical Guidelines

The National Comprehensive Cancer Network (NCCN) released revised guidelines in 2026. These guidelines now recommend pleurectomy/decortication (P/D) as the preferred surgical option for pleural mesothelioma. Extrapleural pneumonectomy (EPP) is recommended only for rare cases. Additionally, surgery is no longer listed as a treatment option for stage 2 through stage 4 pleural mesothelioma of any cell type.

💰 Treatment Costs and Insurance

As of October 2026, the average wholesale price for Keytruda® is about $10,000 per 100 mg vial. The overall treatment cost may vary based on dosage and insurance coverage. For the combination of Opdivo® and Yervoy®, the average wholesale price for Opdivo® is around $7,000 per 100 mg vial, while Yervoy® costs about $1,200 per 50 mg vial.

📞 Finding Support Resources

Patients and families have access to various resources for mesothelioma treatment and support. The Mesothelioma Applied Research Foundation offers information and guidance on treatment options, while the National Cancer Institute (NCI) provides comprehensive resources, including clinical trial information. These organizations can assist patients in navigating their treatment journey.

📌 Key Points Summary

  • 📅 FDA approved Keytruda® and Opdivo®/Yervoy® for mesothelioma.
  • 🏥 NCCN recommends P/D surgery over EPP.
  • 💰 Treatment costs vary; check dosage and insurance.
  • 📞 Support available from nonprofit organizations.

💡 Tips for Mesothelioma Patients

Go over the details of your own situation with your attorney.

🩺 Understand Treatment Options

Research the latest treatment options available for mesothelioma. New immunotherapies like Keytruda® and the Opdivo® and Yervoy® combination have shown promising results in clinical trials.

📅 Check Clinical Trial Eligibility

Consider participating in clinical trials. Enrollment periods may vary, so consult with healthcare providers to find trials that are currently accepting patients.

🏥 Discuss Surgical Options

If surgery is a possibility, discuss the NCCN guidelines with your healthcare team. Understand the differences between pleurectomy/decortication and extrapleural pneumonectomy to make informed decisions.

💰 Review Insurance Coverage

Before starting treatment, review your insurance plan. Coverage for new immunotherapies and surgical options may differ, affecting out-of-pocket costs.

🌐 Seek Support Resources

Look into nonprofit organizations like the Mesothelioma Applied Research Foundation and the National Cancer Institute. These groups provide valuable information and support for patients and families facing mesothelioma.

🏆 Free Options Ranked by User Reviews (2026)

No national paid service in this area met the review threshold, so this section lists free government and nonprofit resources available to those affected by mesothelioma.

🥇 1. Mesothelioma Applied Research Foundation

This nonprofit organization offers extensive resources for mesothelioma patients. They provide information on treatment options, access to clinical trials, and support for navigating the healthcare system. Families can benefit from their guidance in understanding the complexities of mesothelioma care.

🥈 2. National Cancer Institute (NCI)

The NCI serves as a comprehensive resource for mesothelioma information. They offer detailed guides on treatment options, clinical trials, and support resources. Patients can find valuable information about research advancements and access to specialists through their platform.

🥉 3. Cancer Support Community

This organization provides emotional support and resources for cancer patients, including those with mesothelioma. They offer online support groups, educational materials, and personalized assistance to help patients and families cope with the challenges of a cancer diagnosis.

4️⃣ American Cancer Society

The American Cancer Society offers a wealth of information on cancer prevention, treatment, and support resources. They provide educational materials on mesothelioma, including treatment options and support groups for patients and caregivers.

5️⃣ Veterans Affairs (VA)

For veterans affected by mesothelioma, the VA provides resources and support tailored to their needs. They offer information on benefits, treatment options, and how to access care specifically for veterans exposed to asbestos.

🔎 What to Check Before Paying for Help

  • 🔍 Research the organization’s credentials.
  • 📊 Look for user reviews or testimonials.
  • 📞 Verify the services offered and any associated costs.
  • 📅 Confirm the organization’s nonprofit status.

❓ Frequently Asked Questions

❔ What new treatments are available for mesothelioma in 2026?

New treatments like Keytruda® and the Opdivo® and Yervoy® combination received FDA approval. These immunotherapies offer additional options for patients with advanced or metastatic pleural mesothelioma.

🏥 What are the current surgical options for mesothelioma?

The NCCN now recommends pleurectomy/decortication (P/D) as the preferred surgical method. Extrapleural pneumonectomy (EPP) is only for rare cases and is not recommended for most patients.

💰 How much do new mesothelioma treatments cost?

Keytruda® costs about $10,000 per 100 mg vial, while Opdivo® and Yervoy® cost around $7,000 and $1,200 per vial, respectively. Total treatment costs depend on dosage and insurance coverage.

📅 Are there clinical trials for mesothelioma patients?

Yes, there are ongoing clinical trials for mesothelioma treatments. Patients should consult with their healthcare providers to explore participation and availability.

🌐 Where can I find support for mesothelioma?

Organizations like the Mesothelioma Applied Research Foundation and the National Cancer Institute offer valuable support and resources for patients and families dealing with mesothelioma.

📞 How can I access clinical trial information?

The National Cancer Institute provides comprehensive information on clinical trials, including eligibility criteria and contact details for trial coordinators. Patients are encouraged to reach out to their healthcare providers for assistance.

⚖️ Recent Cases Related to Mesothelioma

Recent court rulings have addressed various aspects of mesothelioma claims, including exposure liability and compensation. Understanding these rulings can help families navigate the legal landscape surrounding mesothelioma cases.

For more recent rulings, please check more rulings on the news page.

End of October 2026 Update






Mesothelioma Drugs: Doxurbicin



 



 

Doxurbicin


What is Doxurbicin?



 



 



Doxurbicin is sued in combination with other drugs to treat certain types of cancer (primarily bladder, lung, stomach and ovarian cancer). Doxurbicin is administered as a powder or solution and is mixed with liquid to be injected through an IV. Doxurbicin is administered once every 3 to 4 weeks and the length of treatment is dependent on the types of drugs you are currently receiving, your medical condition, how well you respond to said treatment and the severity of your cancer. 



 



 



In general, there are three traditional mesothelioma treatments: surgery to extract the cancerous cells from the body (only applied to patients lucky enough to detect the disease at an early stage), chemotherapy, which utilizes a variety of drugs to kill the cancer and radiation therapy, which administers high doses of x-rays to terminate the cancerous cells. Frequently, mesothelioma patients must undergo a combination of these treatment options to prolong life. 



 



 



Doxurbicin is currently not available for clinical use. The patent for the drug expired during the winter of 2009; however, Doxurbicin is protected against generic competitors until 2014 because the Food and Drug Administration deems the drug as an “orphan drug”—a designation that awards Doxurbicin an extended protection as a way of rewarding pharmaceutical companies for researching and producing drugs for rare diseases. Doxurbicin is classified as an orphan drug because it affects less than 200,000 people in the United States. 



 



Adverse Side Effects of Doxurbicin:



 



 



Adverse side effects of Doxurbicin include: vomiting, hair loss, nausea and life-threatening heart damage. Moreover, Doxurbicin can cause neutropenia, which is a decrease in white blood cells.More mild side effects of Doxurbicin include: discoloration of urine and fatigue. 



When cumulative dosage of Doxurbicin increases to 550 mg, the risks of developing heart problems dramatically increases. Doxurbicin cardiotoxicity is characterized by dose-dependent declines in mitochondirla oxidative phosphorylation. 



 



 



How does Doxurbicin Fight Mesothelioma?



 



 



Doxurbicin may prove effective in combatting mesothelioma cancer because the drug interacts with DNA by way of inhibition and intercalation. This impedes the progression of the enzyme topoisomerase II which relaxes supercoils in DNA strands for transcription. Doxurbicin brings stability to the topoisomerase II complex after it breaks down the DNA chain for replication, inhibiting the DNA double helix from resealing and thereby halting the process of replication. As a result, mesothelioma cancer cells are blocked from spreading and proliferating beyond the disease’s point of origin. Doxurbicin’s efficacy rates; however, are elastic to diagnosis. If mesothelioma is not caught in its early stages proliferation will already have occurred.